Literature DB >> 30191054

Prognostic signatures from hepatocellular carcinoma biopsy.

Luca Marzi1, Erica Villa1.   

Abstract

Entities:  

Keywords:  hepatocellular carcinoma; liver biopsy; molecular classification; prognostic signature

Year:  2017        PMID： 30191054      PMCID： PMC6095164          DOI： 10.2217/hep-2017-0016

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  33 in total

Review 1.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

2.  A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Authors:  S Chevret; J C Trinchet; D Mathieu; A A Rached; M Beaugrand; C Chastang
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

3.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors:  Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

4.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Authors:  H Okabe; S Satoh; T Kato; O Kitahara; R Yanagawa; Y Yamaoka; T Tsunoda; Y Furukawa; Y Nakamura
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

5.  Molecular classification of hepatocellular carcinoma: potential therapeutic implications.

Authors:  Nicolas Goossens; Xiaochen Sun; Yujin Hoshida
Journal:  Hepat Oncol       Date:  2015

6.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

Authors:  Ju-Seog Lee; In-Sun Chu; Jeonghoon Heo; Diego F Calvisi; Zongtang Sun; Tania Roskams; Anne Durnez; Anthony J Demetris; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

7.  Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma.

Authors:  Suk Mei Wang; London Lucien P J Ooi; Kam M Hui
Journal:  Clin Cancer Res       Date:  2007-11-01       Impact factor: 12.531

8.  A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

Authors:  Jean-Charles Nault; Aurélien De Reyniès; Augusto Villanueva; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Thomas Decaens; Dominique Franco; Sandrine Imbeaud; Francis Rousseau; Daniel Azoulay; Jean Saric; Jean-Frédéric Blanc; Charles Balabaud; Paulette Bioulac-Sage; Alexis Laurent; Pierre Laurent-Puig; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2013-04-06       Impact factor: 22.682

9.  Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinoma.

Authors:  Zuzanna Makowska; Tujana Boldanova; David Adametz; Luca Quagliata; Julia E Vogt; Michael T Dill; Mathias S Matter; Volker Roth; Luigi Terracciano; Markus H Heim
Journal:  J Pathol Clin Res       Date:  2016-02-05

10.  Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.

Authors:  Fabio Farinati; Alessandro Vitale; Gaya Spolverato; Timothy M Pawlik; Teh-la Huo; Yun-Hsuan Lee; Anna Chiara Frigo; Anna Giacomin; Edoardo G Giannini; Francesca Ciccarese; Fabio Piscaglia; Gian Lodovico Rapaccini; Mariella Di Marco; Eugenio Caturelli; Marco Zoli; Franco Borzio; Giuseppe Cabibbo; Martina Felder; Rodolfo Sacco; Filomena Morisco; Elisabetta Biasini; Francesco Giuseppe Foschi; Antonio Gasbarrini; Gianluca Svegliati Baroni; Roberto Virdone; Alberto Masotto; Franco Trevisani; Umberto Cillo
Journal:  PLoS Med       Date:  2016-04-26       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.